Managing Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in the Digital Era: Overcoming Barriers to Lifestyle Change
Cureus · 25.05.2025
DOI: 10.7759/cureus.84803 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cureus, erschienen am 25.05.2025. Verfasst von Stanislav Kravchuk und 4 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology, Danylo Halytsky Lviv National Medical University, Lviv, UKR. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Obesity presents a significant global health challenge due to its association with a range of systemic disorders. One such condition is metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD), which has become the most common chronic liver disease worldwide. The prevalence of MASLD is closely linked to obesity, type 2 diabetes, and sedentary lifestyles, posing substantial risks for liver-related morbidity and extrahepatic complications such as cardiovascular and renal diseases. Despite recent advancements in pharmacological treatments, lifestyle modification remains the cornerstone of MASLD management. This review summarizes current evidence on lifestyle interventions, focusing on weight loss, dietary improvements, and increased physical activity. It also explores barriers to implementation, including socioeconomic factors, limited patient awareness, and stigma, while highlighting innovative strategies such as group-based programs, web-based interventions, and mobile technologies. As MASLD continues to rise globally, prioritizing lifestyle-based and scalable approaches will be critical to reducing its burden and improving patient outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Gastroenterology, Danylo Halytsky Lviv National Medical University, Lviv, UKR.
- Internal Medicine, Corewell Health William Beaumont University Hospital, Royal Oak, USA.
- Internal Medicine, Jagiellonian University Medical College, Krakow, POL.
- Business, Willamette University, Portland, USA.
Zitieren
APA
Kravchuk, S., Bychkov, M., Kozyk, M., Strubchevska, O., & Kozyk, A. (2025). Managing Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in the Digital Era: Overcoming Barriers to Lifestyle Change. Cureus. https://doi.org/10.7759/cureus.84803
Vancouver
Kravchuk S, Bychkov M, Kozyk M, Strubchevska O, Kozyk A. Managing Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in the Digital Era: Overcoming Barriers to Lifestyle Change. Cureus. 2025. doi:10.7759/cureus.84803
BibTeX
@article{Kravchuk2025,
author = {Kravchuk, Stanislav and Bychkov, Mykola and Kozyk, Marko and Strubchevska, Olena and Kozyk, Aleksandra},
title = {Managing Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in the Digital Era: Overcoming Barriers to Lifestyle Change},
journal = {Cureus},
year = {2025},
doi = {10.7759/cureus.84803}
}
EUVIMED